Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy

OBJECTIVE: Use of tumour necrosis factor inhibitors (TNFi) has proved to be an important step forward in the treatment of axial spondyloarthritis (axSpA), but the duration of the therapy as well as the management in case of low disease activity (LDA) or remission are not clearly established. Current...

Descripción completa

Detalles Bibliográficos
Autores principales: Sebastian, Agata, Wojtala, Patryk, Lubiński, Łukasz, Mimier, Małgorzata, Chlebicki, Arkadiusz, Wiland, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647530/
https://www.ncbi.nlm.nih.gov/pubmed/29056769
http://dx.doi.org/10.5114/reum.2017.69775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647530/
https://www.ncbi.nlm.nih.gov/pubmed/29056769
http://dx.doi.org/10.5114/reum.2017.69775

Ejemplares similares